Latest Updates and News
Mukhyamantri Mufat Ilaj Yojna
Planning and Infrastructure
List of Civil Hospitals
List of CHC and PHC and Sub Center
RTI Act 2005 Section 4 of 1 of b of i
Performa for New Institute
New Health Institutions Established
Year Wise Construction Budget
Instructions and Rules
Chief Secretary Instructions
Finance Department Instructions
Departmental Service Rules
Family Welfare Programme
Departmental Service Rules
Rules Norms RTI Act 2005- Section 4
Pre-natal Diagnostic Techniques
Public Notice of PC and PNDT Act
Standard Operating Procdure under PNDT
PNDT Note upto Sept 2015
Cumulative PNDT note
Registration of Manufacturers-Retailers-Distributi
Circular reg Registration of Manufacturer-Retailer
Tuberculosis Control Program
Information of Tuberculosis RNTCP
Checklist for 24x7 Accidents and Emergency
Inspection Performa for Operation Theater Complex
CHC And Hospital Inspection Protocol
Guidelines on the Use of Larvivorous fish for vect
MALARIA CONTROL STRATEGIES
National Drug Policy on Malaria 2010
Treatment and use of Insecticide-Treated Mosquito
Urban Malaria Scheme
Malaria data 2008 to 2012
Dengue Data for 2008 to 2012
District wise JE confirmed cases 2008-2012
Information about Chikungunya
Data of Chikungunya for the year 2008 to 2012
Revised Nursing Policy
Civil Registration System
Haryana Health Services 2014-15
Annual Report of Births and Deaths 2013
Manual on Civil Registration System
BAN on Loose Cigarette
Mental Health and De Addiction
List of Empanelled Hospitals
List of Chronic Diseases
Notification Regarding Disablity Certificate
FAQ About PM
Non Communicable Diseases
Free Travel Facility
New Norms for Grant of NOC for New Blood Bank
Tender for Blood Bags and kits for Blood Banks
Contact No. of Civil Surgeons in the State
Other Departments Orders or Notifications
National Rural Health Mission
Structure of State Health Mission
Tender for Testing of Drugs and Consumable
Essential Drug List and Hry. Rate Contract
Tender for English Medicine
RTI Act Ayush Department
Food and Drug Department
Haryana Medical Council
State Institute of Health and Family Welfare
Q. How is Japanese encephalitis transmitted?
By rice field breeding mosquitoes (primarily the
group) that become infected with Japanese encephalitis virus (a flavivirus antigenically related to St. Louis encephalitis virus).
Q. How do people get Japanese encephalitis?
By the bite of mosquitoes infected with the Japanese encephalitis virus.
Q. What is the basic transmission cycle?
Mosquitoes become infected by feeding on domestic pigs and wild birds infected with the Japanese encephalitis virus. Infected mosquitoes then transmit the Japanese encephalitis virus to humans and animals during the feeding process. The Japanese encephalitis virus is amplified in the blood systems of domestic pigs and wild birds.
Q. Could you get the Japanese encephalitis from another person?
No, Japanese encephalitis virus is NOT transmitted from person-to-person. For example, you cannot get the virus from touching or kissing a person who has the disease, or from a health care worker who has treated someone with the disease.
Q. Could you get Japanese encephalitis from animals other than domestic pigs, or from insects other than mosquitoes?
No. Only domestic pigs and wild birds are carriers of the Japanese encephalitis virus.
Q. What are the symptoms of Japanese encephalitis?
Mild infections occur without apparent symptoms other than fever with headache. More severe infection is marked by quick onset, headache, high fever, neck stiffness, stupor, disorientation, coma, tremors, occasional convulsions (especially in infants) and spastic (but rarely flaccid) paralysis.
Q. What is the incubation period for Japanese encephalitis?
Usually 5 to 15 days.
Q. What is the mortality rate of Japanese encephalitis?
Case-fatality rates range from 0.3% to 60%.
Q. How many cases of Japanese encephalitis occur in the world and the U.S.?
Japanese encephalitis is the leading cause of viral encephalitis in Asia with 30-50,000 cases reported annually. Fewer than 1 case/year is reported in U.S. civilians and military personnel traveling to and living in Asia. Rare outbreaks in U.S. territories in Western Pacific have occurred.
Q. How is Japanese encephalitis treated?
There is no specific therapy. Intensive supportive therapy is indicated.
Q. Is the disease seasonal in its occurrence?
Seasonality of the illness varies by country
Q. Who is at risk for getting Japanese encephalitis?
Residents of rural areas in endemic locations, active duty military deployed to endemic areas, and expatriates who visit rural areas. Japanese encephalitis does not usually occur in urban areas.
Q. Where do Japanese encephalitis outbreaks occur?
Japanese encephalitis outbreaks are usually circumscribed and do not cover large areas. They usually do not last more than a couple of months, dying out after the majority of the pig amplifying hosts have become infected. Birds are the natural hosts for Japanese encephalitis. Epidemics occur when the virus is brought into the peridomestic environment by mosquito bridge vectors where there are pigs, which serve as amplification hosts, infecting more mosquitoes which then may infect humans. Countries which have had major epidemics in the past, but which have controlled the disease primarily by vaccination, include China, Korea, Japan, Taiwan and Thailand. Other countries that still have periodic epidemics include Viet Nam, Cambodia, Myanmar, India, Nepal, and Malaysia.
Note: Source Data from CDC
Q. Is there any vaccine available against JE virus in India?
Inactivated Mouse Brain-Derived JE Vaccine is available against JE in India. The Vaccine is prepared by subjecting the mouse brain infected with Nakayama strain of JE virus to a sequence of protamine sulphate treatment, formalin inactivation and ultrafilteration and ammonium sulfate precipitation. The purified product is without myclin basic protean and supplied in a freeze dried form. The Vaccine in manufactured at Central Research Institute, Kasauli, Himachal Pradesh.
Q. Who should be vaccinated against Japanese Encephalitis?
Seroprevalance studies disclose nearly universal infection by early adulthood and in areas where viral transmission is particularly intense Seroprevalance rates may increase during childhood. The age group for immunization should be decided based on available Sero-epidemiological data from the area.
Content on this website is published and managed by Health Department, Haryana Email id: email@example.com,
Nodal Officer for Website:-Ramandeep Singh, Programmer, IT Cell -0172-6627500- Ext.204
website last updated on 29.03.2017